Article info
PDFHOT off the breath
Upfront combination therapy: does the AMBITION study herald a new era in the treatment of pulmonary arterial hypertension?
- Correspondence to Dr Steven D Nathan, Advanced Lung Disease and Transplant Program, Department of Medicine, Inova Heart and Vascular Institute, Falls Church VA 22042, USA; steven.nathan{at}inova.org
Citation
Upfront combination therapy: does the AMBITION study herald a new era in the treatment of pulmonary arterial hypertension?
Publication history
- Received September 17, 2015
- Revised October 19, 2015
- Accepted October 27, 2015
- First published November 23, 2015.
Online issue publication
September 01, 2022
Article Versions
- Previous version (29 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/